Groww Mutual Fund (scheme IB33)
Glenmark Pharmaceuticals Limited · NSE
146 sh · ₹3.41 L
HDFC Mid Cap Fund
3.1% of their portfolio
₹3,325.23 Cr
1,34,08,183 sh
SBI Arbitrage Opportunities Fund
62.0% of their portfolio
₹291.65 Cr
11,76,000 sh
HDFC Large and Mid Cap Fund
86.0% of their portfolio
₹259.92 Cr
10,48,046 sh
ICICI Prudential Arbitrage Fund
0.7% of their portfolio
₹246.19 Cr
10,54,500 sh
HDFC Mutual Fund (scheme HDFCGR)
20.0% of their portfolio
₹219.49 Cr
8,85,046 sh
Nippon India Arbitrage Fund
0.9% of their portfolio
₹163.98 Cr
7,02,375 sh
HDFC Manufacturing Fund
1.4% of their portfolio
₹155.00 Cr
6,25,000 sh
Aditya Birla Sun Life Arbitrage Fund
0.5% of their portfolio
₹133.08 Cr
6,03,750 sh
HDFC Mutual Fund (scheme HDFCAR)
50.0% of their portfolio
₹127.78 Cr
5,15,250 sh
HDFC Pharma and Healthcare Fund
2.3% of their portfolio
₹77.60 Cr
3,12,887 sh
Nippon India Nifty Pharma ETF
3.6% of their portfolio
₹61.89 Cr
2,65,105 sh
Nippon India ETF Nifty Midcap 150
0.9% of their portfolio
₹33.24 Cr
1,42,360 sh
FIIs raised their stake +0.5pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Groww Mutual Fund (scheme IB33)
Glenmark Pharmaceuticals Limited · NSE
146 sh · ₹3.41 L
Nippon India Arbitrage Fund
Glenmark Pharmaceuticals Limited · NSE
7,02,375 sh · ₹163.98 Cr
ICICI Prudential Nifty 200 Momentum 30 ETF
Glenmark Pharmaceuticals Limited · NSE
39,203 sh · ₹9.15 Cr
ICICI Prudential Nifty LargeMidcap 250 Index Fund
Glenmark Pharmaceuticals Limited · NSE
5,347 sh · ₹1.25 Cr
ICICI Prudential Retirement Fund - Hybrid Aggressive Plan
Glenmark Pharmaceuticals Limited · NSE
42,111 sh · ₹9.83 Cr
Groww Mutual Fund (scheme IB54)
Glenmark Pharmaceuticals Limited · NSE
551 sh · ₹12.86 L
Groww Mutual Fund (scheme IB53)
Glenmark Pharmaceuticals Limited · NSE
224 sh · ₹5.23 L
Nippon India Nifty Midcap 150 Index Fund
Glenmark Pharmaceuticals Limited · NSE
99,720 sh · ₹23.28 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
54 announcements on record for this company.
ICICI Prudential BSE Midcap Select ETF
2.6% of their portfolio
₹2.89 Cr
12,529 sh
SBI Nifty Midcap 150 Momentum 50 ETF
2.1% of their portfolio
₹2.78 Cr
11,211 sh
Promoter holding by quarter: Jun 2025 46.6%, Sep 2025 46.6%, Dec 2025 46.6%, Mar 2026 46.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +1.1pp
FII holding by quarter: Jun 2025 20.6%, Sep 2025 20.7%, Dec 2025 19.2%, Mar 2026 20.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.8pp
DII holding by quarter: Jun 2025 17.6%, Sep 2025 18.6%, Dec 2025 20.1%, Mar 2026 19.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −1.1pp
MF holding by quarter: Jun 2025 15.6%, Sep 2025 16.3%, Dec 2025 17.9%, Mar 2026 16.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India ETF Nifty Midcap 150
Glenmark Pharmaceuticals Limited · NSE
1,42,360 sh · ₹33.24 Cr
Nippon India Nifty 500 Momentum 50 Index Fund
Glenmark Pharmaceuticals Limited · NSE
90,465 sh · ₹21.12 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 46.6%, Sep 2025 46.6%, Dec 2025 46.6%, Mar 2026 46.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +1.1pp
FII holding by quarter: Jun 2025 20.6%, Sep 2025 20.7%, Dec 2025 19.2%, Mar 2026 20.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.8pp
DII holding by quarter: Jun 2025 17.6%, Sep 2025 18.6%, Dec 2025 20.1%, Mar 2026 19.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −1.1pp
MF holding by quarter: Jun 2025 15.6%, Sep 2025 16.3%, Dec 2025 17.9%, Mar 2026 16.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
54 announcements on record for this company.